Sheffield has quietly become one of the busiest cities in Yorkshire for private weight loss treatment, and it did not take long for local patients to start asking about the latest development. Foundayo, the brand name for orforglipron, was authorised by the Medicines and Healthcare products Regulatory Agency on 10 August 2026, making the UK the first country in Europe to approve this once-daily GLP-1 weight loss tablet. For Sheffield residents already familiar with Mounjaro and Wegovy, the idea of a needle-free tablet with this level of flexibility has understandably sparked plenty of interest.
Everest Pharmacy has built a strong presence in Sheffield over recent years, supporting patients with everything from private blood testing and travel vaccinations to weight management consultations. Foundayo is the next treatment we are preparing to bring to our Sheffield patients, working alongside our online partner platform, Everslim, so that access is as straightforward as possible once it launches.
This guide is written specifically with Sheffield users in mind, covering what Foundayo is, how the authorisation process works, what to expect from a consultation, and how to get ahead of the queue before it becomes available. If you have questions now, contact our team directly.
What Exactly Is Foundayo?
Foundayo is the UK brand name given to orforglipron, a GLP-1 receptor agonist that has been developed as a once-daily tablet rather than a weekly injection. It sits in the same broad medicine class as semaglutide and tirzepatide, working by mimicking a hormone the body naturally produces after eating, which helps regulate appetite and support a longer feeling of fullness.
The distinction that has generated so much conversation is the format. Where existing GLP-1 treatments have relied on injection pens, Foundayo has been formulated as a stable, orally absorbed tablet. This opens the door to Sheffield patients who have previously been put off GLP-1 treatment purely because of needle anxiety, as well as anyone who simply finds a daily tablet easier to build into their routine than a weekly injection.
Understanding The MHRA Authorisation
The MHRA‘s decision on 10 August 2026 confirmed that orforglipron has met the required UK standards for safety, quality and effectiveness, and did so before any regulator elsewhere in Europe. This is a notable milestone, but it is important for Sheffield patients to understand what it does and does not mean in practice.
Authorisation means the medicine can legally be prescribed in the UK once supply chains, pricing and clinical pathways are in place. It does not mean every pharmacy or clinic can start prescribing it immediately. Providers, including Everest Pharmacy, are now working through the process of securing supply and setting up the appropriate consultation pathway, with the goal of making Foundayo available to Sheffield patients as soon as we responsibly can.
How Foundayo Works In The Body
Foundayo works by activating GLP-1 receptors, which play a central role in how the body regulates hunger and digestion. In practical terms, this can help patients by:
-
- Reducing overall appetite and the frequency of food cravings
- Slowing gastric emptying, which extends the feeling of fullness after meals
- Supporting more consistent blood sugar control, which is why it has also been authorised for type 2 diabetes
- Making it easier to stick to a reduced-calorie eating plan without constant hunger
Foundayo is not designed to be used in isolation. As with Mounjaro and Wegovy, it is intended to support a broader weight loss plan that includes dietary changes and increased physical activity, with the medicine helping to make those changes more manageable rather than replacing them.
A Timeline Of Foundayo’s Progress So Far
For Sheffield patients trying to understand where things currently stand, this timeline sets out the key milestones reached so far.
| Date | Development |
|---|---|
| Earlier 2026 | Orforglipron submitted for regulatory review in the UK as part of a wider international rollout |
| 10 August 2026 | MHRA authorises orforglipron (Foundayo) for weight management and type 2 diabetes, the first approval of its kind in Europe |
| Now | Providers, including Everest Pharmacy, finalising supply and clinical pathways ahead of launch |
| Coming soon | Foundayo expected to become available through Everest Pharmacy and Everslim |
We will update Sheffield patients as soon as firm launch dates are confirmed, following approval for use on the 24th of August.
Foundayo Versus The Injectable Options Sheffield Patients Already Know
Many Sheffield patients considering Foundayo will already have experience of, or at least familiarity with, Mounjaro and Wegovy. Here is a straightforward comparison of the three.
| Feature | Foundayo (Orforglipron) | Mounjaro (Tirzepatide) | Wegovy (Semaglutide) |
|---|---|---|---|
| Form | Oral tablet | Weekly injection | Weekly injection, or newer daily pill |
| Needle-free | Yes | No | Injection: no. Pill: yes |
| Mechanism | GLP-1 receptor agonist | Dual GLP-1/GIP receptor agonist | GLP-1 receptor agonist |
| Currently available in Sheffield | Launching soon | Yes, via Everest Pharmacy | Yes, via Everest Pharmacy |
It is too early to give a confident answer on how Foundayo’s real-world effectiveness will compare to Mounjaro specifically, as UK usage data is still limited. If you would like to understand more about the injectable option many Sheffield patients already use, our guide on Mounjaro vs Wegovy is a helpful starting point.
What A Foundayo Consultation Is Expected To Involve
Once Foundayo becomes available through Everslim, a consultation at Everest Pharmacy is likely to follow a similar structure to our existing weight loss assessments. Patients can generally expect the process to include:
-
- A review of your current weight, BMI and weight loss history
- A discussion of any existing health conditions, particularly thyroid, pancreatic, kidney or liver concerns
- A check of your current medications for any potential interactions
- An explanation of how to take the tablet correctly and what to expect in the early weeks
- A plan for ongoing monitoring and follow-up
Where relevant, some patients may also be offered baseline blood testing as part of a thorough assessment. Everest Pharmacy already provides private blood testing in Sheffield, which can be a useful step for patients wanting a clearer picture of their health before starting any new weight loss treatment.
Who Foundayo May Not Be Suitable For
As with other GLP-1 medicines, Foundayo is not expected to be appropriate for every patient. Based on the wider GLP-1 medicine class, it is likely to carry similar precautions to Mounjaro and Wegovy, and may not be suitable for those who:
-
- Have a personal or family history of certain thyroid cancers
- Have a history of pancreatitis
- Have significant liver or kidney impairment
- Are pregnant, breastfeeding, or planning a pregnancy
- Are already taking another GLP-1 receptor agonist
Final eligibility criteria will be confirmed once Foundayo’s UK product information is fully published, and a proper one-to-one assessment will always be required before treatment can begin.
Common Side Effects To Be Aware Of
Foundayo’s side effect profile is expected to be broadly similar to other GLP-1 medicines, since they work through the same underlying pathway. Commonly reported effects with this class of medicine include:
-
- Nausea, particularly in the early weeks or when the dose is increased
- Diarrhoea or constipation
- Indigestion or bloating
- Reduced appetite, which is also the intended treatment effect
- Tiredness or headache
Most digestive side effects tend to be mild to moderate and settle over time as the body adjusts. Sheffield patients starting Foundayo in future will be given clear, medicine-specific safety guidance directly from their prescribing clinician, rather than relying on general online information alone.
Why Sheffield Patients Are Watching This Launch Closely
A few factors help explain why interest in Foundayo has been particularly strong across Sheffield:
-
- Growing local demand for weight management support: Sheffield has seen a steady rise in patients seeking private weight loss treatment, and any credible new oral option is likely to attract significant attention.
- Needle aversion remains a real barrier: A meaningful number of patients who could benefit from GLP-1 treatment have avoided it specifically because of the injection, and Foundayo removes that barrier entirely.
- Interest in simpler daily routines: Unlike some oral GLP-1 medicines, Foundayo does not appear to require strict food or water timing, which may suit patients balancing shift work, studying, or busy family schedules.
- Established trust in local providers: Sheffield patients already turn to Everest Pharmacy for weight management support, making it a natural first place to ask about Foundayo once it becomes available.
How To Register Interest Ahead Of Launch
Because there is a wait list to access Foundayo, the most useful step Sheffield patients can take now is registering interest so they are notified the moment assessments open. This can be done by:
-
- Registering directly on the Foundayo page
- Contacting our Sheffield team to ask about being added to our notification list
- Booking an assessment for a currently available treatment in the meantime, so you are not left waiting unnecessarily
Starting Treatment In Sheffield While You Wait
If you are ready to begin weight loss treatment now, our Sheffield team can currently assess you for:
-
- Mounjaro (tirzepatide), one of the most effective GLP-1 treatments currently available in the UK
- Wegovy injection (semaglutide), an established option with a strong track record
- The Wegovy pill (oral semaglutide), already available as a needle-free tablet through Everest Pharmacy
Starting one of these options now does not close the door to Foundayo later. Once it becomes available, your prescriber can help you decide whether continuing your current treatment or switching is the right approach for you.
Book A Consultation With Everest Pharmacy Sheffield
Whether you want to register your interest in Foundayo ahead of the Everslim launch, or you would rather start your weight loss journey today with a currently available treatment, our Sheffield team is here to help. We aim to be honest and clear with patients about what is genuinely available now versus what is still on its way, so you can make an informed decision either way.
Contact our team today, or explore our full weight loss services page for more information.
Frequently Asked Questions
Can Sheffield patients register interest in Foundayo before it launches nationally?
Yes. Registering on the Everslim Foundayo page or contacting our Sheffield team directly is the best way to be notified as soon as assessments open, regardless of where you are based in the UK.
Will I need a blood test before starting Foundayo in Sheffield?
This will depend on your individual assessment. Some patients may be offered baseline blood testing as part of a thorough consultation, which Everest Pharmacy already provides locally in Sheffield.
Is Foundayo expected to be cheaper than Mounjaro in Sheffield?
Our Sheffield team will share accurate cost information as soon as it becomes available ahead of launch, but we anticipating providing medication from £109 per month.
Can I have a face-to-face Foundayo consultation in Sheffield, or is it online only?
Once available, we expect to offer both options, an in-person assessment locally or a remote consultation through Everslim, so patients can choose whichever suits them best.
Does the MHRA authorisation mean Foundayo has been tested on UK patients specifically?
MHRA authorisation is based on clinical trial data submitted by the manufacturer, which typically includes international study populations rather than UK-only trials. This is standard practice for new medicine approvals.
If I’m already on Mounjaro in Sheffield, should I wait for Foundayo instead?
This depends on how you are responding to your current treatment. If Mounjaro is working well for you, there is no need to pause or switch. Speak to your prescriber before making any changes.
What happens if I register interest but decide not to proceed once Foundayo launches?
Registering your interest simply ensures you are notified when Foundayo becomes available. There is no obligation to proceed with treatment, and a full consultation would take place before anything is prescribed.
Are there any Sheffield-specific eligibility rules for Foundayo?
No. Eligibility will be based on individual clinical assessment rather than location, following the same standards Everest Pharmacy applies across all our branches.
Get Ready For Foundayo With Everest Pharmacy Sheffield
Foundayo’s UK authorisation marks a genuinely exciting step forward for weight loss treatment, and Sheffield patients are well placed to be among the first to access it once it launches. Whether you would like to register your interest now or start with a currently available treatment, our team is ready to help.
Contact us today, or book an appointment with our Sheffield team to discuss your options.